Deletion of specific MGF360 and 505 genes in ASFV attenuates the virus and induces protection, providing potential targets for vaccine development.
No takes yet. Share an insight, caveat, or question.
Targeted MGF deletions may guide ASFV vaccine candidates; leaves open optimal combinations for protection against circulating genotype II strains.
Rathakrishnan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: